Open access
Aug 2026
IFI44L modulates chemoradiotherapy sensitivity and CD8+ T cell infiltration in colorectal cancer
By promoting CCL5-mediated CD8+ T cell recruitment, IFI44L links tumor-intrinsic molecular alterations with antitumor immune responses and may represent a potential biomarker or therapeutic target for improving CRT efficacy.
Linlin Zheng, Meng-Jie Li, Ruoqing Yan et al.
· Frontiers in Oncology · 0 citations